Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | WSD-0628 |
Synonyms | |
Therapy Description |
WSD-0628 inhibits ATM, which potentially increases radiosensitivity and decreases tumor cell survival (Cancer Res (2022) 82 (12_Supplement): 3305). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
WSD-0628 | WSD0628|WSD 0628 | ATM Inhibitor 13 | WSD-0628 inhibits ATM, which potentially increases radiosensitivity and decreases tumor cell survival (Cancer Res (2022) 82 (12_Supplement): 3305). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT05917145 | Phase I | WSD-0628 | Clinical Trial of the ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Recurrent Brain Tumors | Recruiting | USA | 0 |